Atomistic Tuning of the GeoCas9 Recognition Lobe Modulates Allosteric Motions and Guide RNA Interactions
Core Concepts
Mutations within the recognition (Rec) lobe of the thermophilic GeoCas9 enzyme modulate its structural dynamics and guide RNA (gRNA) binding affinity, with modest impacts on DNA cleavage function.
Abstract
This study provides new insights into the structural, dynamic, and functional role of the thermophilic GeoCas9 recognition (Rec) lobe. Novel constructs of the GeoRec1 and GeoRec2 subdomains, as well as the intact GeoRec lobe, show a high structural similarity to the domains in full-length GeoCas9, enabling solution NMR experiments to capture the intrinsic allosteric motions across GeoRec2.
The study reveals the existence of μs-ms timescale motions within GeoRec2 that are associated with allosteric signaling and enzyme function. Two mutations, K267E and R332A, introduced into the GeoRec2 subdomain enhanced and redistributed these μs-ms motions. The mutations also diminished the affinity of GeoRec for the guide RNA (gRNA), as well as the stability of the full-length GeoCas9 ribonucleoprotein (RNP) complex, as measured by NMR and microscale thermophoresis (MST).
Despite these biophysical changes, the functional impact of the single-point mutations on DNA cleavage activity and specificity of full-length GeoCas9 was relatively modest. This suggests that multiple additive (or synergistic) mutations within GeoRec may be required to fine-tune GeoCas9 activity or specificity to a larger degree. The study highlights the evolutionary resilience of the thermophilic GeoCas9 system and the complexity in rationally engineering Cas9 variants with enhanced properties.
Atomistic Tuning of the GeoCas9 Recognition Lobe Modulates Allosteric Motions and Guide RNA Interactions
Stats
The global chemical exchange rate (kex) derived from CPMG relaxation dispersion experiments was 147 ± 41 s-1 for wild-type GeoRec2, 376 ± 89 s-1 for the K267E variant, and 142 ± 28 s-1 for the R332A variant.
The dissociation constant (Kd) for the binding of wild-type GeoRec to the 39-nt guide RNA was 2.95 ± 0.53 μM, while the Kd values for the K267E and R332A variants were 6.67 ± 2.0 μM and 4.02 ± 1.34 μM, respectively.
The thermal unfolding midpoint (Tm) of wild-type full-length GeoCas9 was ~60°C, which increased to 73°C upon formation of the RNP complex. The Tm values for the K267E and R332A GeoCas9 variants in the RNP complex were 70°C and 61°C, respectively.
Quotes
"The intuitive manipulation of specific amino acids to alter the activity or specificity of CRISPR-Cas9 has been a topic of great interest."
"Ultimately, this work provides an avenue by which to modulate the structure, motion, and nucleic acid interactions at the level of the Rec lobe of GeoCas9, setting the stage for future studies of GeoCas9 variants and their effect on its allosteric mechanism."
How might the structural and dynamic properties of the GeoRec lobe be further tuned to enhance the specificity and activity of GeoCas9 for therapeutic applications?
To enhance the specificity and activity of GeoCas9 for therapeutic applications, further tuning of the structural and dynamic properties of the GeoRec lobe could involve a multi-faceted approach. One strategy could be to explore additional mutations in key residues identified as allosteric hotspots in the GeoRec lobe. By systematically introducing mutations in these regions and characterizing their effects on protein dynamics, gRNA binding affinity, and RNP stability, researchers can identify combinations of mutations that optimize the function of GeoCas9. Additionally, leveraging computational modeling and molecular dynamics simulations can provide insights into how specific mutations impact the conformational dynamics and nucleic acid interactions of GeoCas9, guiding the design of variants with enhanced specificity and activity. Furthermore, structural studies such as cryo-EM or X-ray crystallography can offer detailed insights into the conformational changes induced by mutations in the GeoRec lobe, aiding in the rational design of engineered variants with improved therapeutic potential.
What are the potential limitations of relying solely on single-point mutations to engineer Cas9 variants with desired properties, and how could a more comprehensive mutagenesis approach be leveraged?
While single-point mutations have been valuable in modulating the function of Cas9 variants, there are limitations to relying solely on this approach for engineering variants with desired properties. One limitation is the potential for limited impact on protein function, as single mutations may not be sufficient to achieve the desired level of specificity or activity. Additionally, single-point mutations may not capture the complex interplay of structural and dynamic factors that contribute to Cas9 function, necessitating a more comprehensive mutagenesis approach.
A more comprehensive mutagenesis approach could involve the systematic screening of multiple mutations across different regions of the Cas9 protein, including the Rec lobe, HNH domain, and RuvC domain. By generating libraries of Cas9 variants with diverse mutations and characterizing their functional properties, researchers can identify synergistic effects between mutations that lead to enhanced specificity and activity. High-throughput screening methods, such as deep mutational scanning or directed evolution, can be employed to efficiently explore a wide range of mutations and their combinatorial effects on Cas9 function. This approach allows for the identification of optimal mutation combinations that fine-tune the structural and dynamic properties of Cas9 for specific therapeutic applications.
Given the evolutionary resilience of the GeoCas9 system, what other strategies beyond protein engineering could be explored to expand the utility of this thermophilic CRISPR-Cas9 variant?
Beyond protein engineering, several strategies could be explored to expand the utility of the thermophilic GeoCas9 variant. One approach could involve optimizing the delivery and expression of GeoCas9 in target cells, particularly in vivo applications. Developing efficient delivery systems, such as viral vectors or nanoparticles, that can transport GeoCas9 to specific tissues or organs with high efficiency and minimal off-target effects is crucial for therapeutic applications. Additionally, optimizing the expression levels and stability of GeoCas9 in target cells can enhance its efficacy and reduce potential cytotoxicity.
Furthermore, exploring the use of GeoCas9 in combination with other genome editing tools, such as base editors or prime editors, can expand its utility for precise genome editing applications. By leveraging the unique properties of GeoCas9 in conjunction with complementary editing technologies, researchers can achieve more precise and versatile genome editing outcomes. Additionally, investigating the potential synergies between GeoCas9 and other CRISPR systems, such as Cpf1 or C2c2, could lead to the development of novel genome editing platforms with enhanced capabilities and specificity. Collaborations with experts in bioinformatics and computational biology can also help in optimizing the design and targeting of GeoCas9 for specific genomic loci, further expanding its utility in diverse research and therapeutic settings.
0
Visualize This Page
Generate with Undetectable AI
Translate to Another Language
Scholar Search
Table of Content
Atomistic Tuning of the GeoCas9 Recognition Lobe Modulates Allosteric Motions and Guide RNA Interactions
Atomistic Tuning of the GeoCas9 Recognition Lobe Modulates Allosteric Motions and Guide RNA Interactions
How might the structural and dynamic properties of the GeoRec lobe be further tuned to enhance the specificity and activity of GeoCas9 for therapeutic applications?
What are the potential limitations of relying solely on single-point mutations to engineer Cas9 variants with desired properties, and how could a more comprehensive mutagenesis approach be leveraged?
Given the evolutionary resilience of the GeoCas9 system, what other strategies beyond protein engineering could be explored to expand the utility of this thermophilic CRISPR-Cas9 variant?